Trexquant Investment
NPCE icon

Trexquant Investment’s Neuropace NPCE Stock Holding History

Trexquant Investment’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-61,969
Closed -$815K – 2126
2026
Q1 		$815K Buy
61,969
+22,813
+58% +$342K 0.01% 1298
2025
Q4 		$605K Sell
39,156
-17,880
-31% -$239K 0.01% 1301
2025
Q3 		$588K Buy
57,036
+12,206
+27% +$115K 0.01% 1287
2025
Q2 		$499K Buy
44,830
+21,186
+90% +$265K 0.01% 1269
2025
Q1 		$291K Buy
+23,644
New +$296K ﹤0.01% 1398

Other funds holding NPCE

Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
First Light Asset Management
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Trexquant Investment's NPCE Position: Q2 2026 in Review

Trexquant Investment sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 61,969 shares — an estimated $815K sold.

Trexquant Investment first reported a position in NPCE in Q1 2025 and held it in 5 quarters. The position peaked at $815K in Q1 2026. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Trexquant Investment reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 61,969 Neuropace shares in Q2 2026, an estimated $815K.
  • Trexquant Investment first reported a position in Neuropace in Q1 2025 and held it in 5 quarters.
  • Trexquant Investment's Neuropace position peaked at $815K in Q1 2026.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.